2,3,5,6-Tetrafluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide

ID: ALA2333417

PubChem CID: 71299337

Max Phase: Preclinical

Molecular Formula: C8H7F4NO5S2

Molecular Weight: 337.27

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)CCO)c(F)c1F

Standard InChI:  InChI=1S/C8H7F4NO5S2/c9-3-5(11)8(20(13,17)18)6(12)4(10)7(3)19(15,16)2-1-14/h14H,1-2H2,(H2,13,17,18)

Standard InChI Key:  WZGGLNWNBUCLIP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 20  0  0  0  0  0  0  0  0999 V2000
   29.7600   -1.9975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7589   -2.8171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4669   -3.2260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1766   -2.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1738   -1.9939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4651   -1.5887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4627   -0.7715    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.1692   -0.3608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6665   -0.9782    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0462   -0.0578    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8799   -1.5827    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.0522   -1.5891    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.0509   -3.2251    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.8849   -3.2241    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.4667   -4.0432    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   29.7589   -4.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7587   -5.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0509   -5.6773    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2514   -3.8259    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0409   -4.6184    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  7 10  2  0
  5 11  1  0
  1 12  1  0
  2 13  1  0
  4 14  1  0
  3 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 15 19  2  0
 15 20  2  0
M  END

Associated Targets(Human)

CA13 Tclin Carbonic anhydrase XIII (905 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA7 Tclin Carbonic anhydrase VII (2318 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA3 Tclin Carbonic anhydrase III (753 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA4 Tclin Carbonic anhydrase IV (2163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA5A Tclin Carbonic anhydrase VA (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA5B Tclin Carbonic anhydrase VB (957 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA6 Tclin Carbonic anhydrase VI (993 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA14 Tclin Carbonic anhydrase XIV (1305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 337.27Molecular Weight (Monoisotopic): 336.9702AlogP: -0.34#Rotatable Bonds: 4
Polar Surface Area: 114.53Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 5.48CX Basic pKa: CX LogP: -0.55CX LogD: -1.45
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.58Np Likeness Score: -0.80

References

1. Dudutienė V, Zubrienė A, Smirnov A, Gylytė J, Timm D, Manakova E, Gražulis S, Matulis D..  (2013)  4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.,  21  (7): [PMID:23394791] [10.1016/j.bmc.2013.01.008]
2. Dudutienė V, Matulienė J, Smirnov A, Timm DD, Zubrienė A, Baranauskienė L, Morkūnaite V, Smirnovienė J, Michailovienė V, Juozapaitienė V, Mickevičiūtė A, Kazokaitė J, Bakšytė S, Kasiliauskaitė A, Jachno J, Revuckienė J, Kišonaitė M, Pilipuitytė V, Ivanauskaitė E, Milinavičiūtė G, Smirnovas V, Petrikaitė V, Kairys V, Petrauskas V, Norvaišas P, Lingė D, Gibieža P, Capkauskaitė E, Zakšauskas A, Kazlauskas E, Manakova E, Gražulis S, Ladbury JE, Matulis D..  (2014)  Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX.,  57  (22): [PMID:25358084] [10.1021/jm501003k]

Source